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Abstract. Distamycin and netropsin are two oligopeptides which bind to DNA in a non-
intercalative manner. Analogues of distamycin have been synthesized and their binding with
poly d(A-T) studied using ultraviolet absorption spectroscopy. Preliminary biological activity
tests on a gram positive bacteria using these analogues have also been carried out.
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Introduction
 
The antitumour activity of a number of naturally occurring as well as synthetic
compounds has been demonstrated although their mode of action remains largely
unknown. The oligopeptide antibiotics, netropsin and distamycin bind in a non-
intercalative mode to B-DNA (Zimmer, 1975). These molecules are composed of
pyrrole rings joined by peptide units. They show antibacterial, antiviral and antitumour 
properties (Zimmer, 1975) in some systems as well as inhibition of DNA synthesis in 
vitro (DiMarco et al., 1964). They have unusually high affinity for A-T rich regions 
(Zimmer, 1975; Luck et al., 1974) and it is believed that hydrogen bonds are formed 
between O2 of thymine and N3 of adenine with N–H atoms of the peptide backbone
(Zasedatelev et al., 1976; Berman et al., 1979). Though it has not been conclusively
proved, it is generally believed that the DNA binding property is responsible for the 
biological activity of these molecules.
From an examination of the crystal structures of netropsin (Berman et al., 1979; 
figure 1 a) and distamycin analogues (Gurskaya et al., 1979; figure 1b) it is readily seen 
that these molecules prefer bow-shaped structures with curved backbone which places 
the amido N-H groups in favourable positions for hydrogen bonding to the DNA base 
atoms mentioned above. Model building studies have shown that with small torsional 
changes from the crystal structures, these molecules attain geometrical shapes which
would enable them fit well in the minor groove of B-DNA (Chandra et al., 1972;
Kolchinskii et al., 1975). Therefore, the design of any molecule with binding capacity
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Figure 1. (a)  A projection of the structure of the netropsin molecule. (b) A projection of the
structure of the distamycin molecule.
Note in the above two molecules, the projection axes are the same to show the curvature of the
backbone which fits into the minor groove of B-DNA.
 
 
and specificity close to that of netropsin and distamycin requires a certain amount of
curvature in the molecule itself, so as to have a stereochemical fit with DNA.
To investigate the role of this curvature in the binding and biological properties of 
such molecules, a novel distamycin analogue was synthesized. N-methyl pyrrole rings
of distamycin were replaced by 1,3 disubstituted benzene rings. This increases the
inherent curvature in the molecule as compared to netropsin or distamycin (Berman et 
al., 1979; Gurskaya et al., 1979). Bis and tris (m-benzamido) compounds prepared by us 
(figure 2) are expected to bind to DNA in a similar fashion as the distamycin class of
drugs (Zimmer et al., 1972). Binding studies of bis, and tris (m-benzamido) compounds
indeed show that the latter binds to poly d(A-T) and causes a significant elevation of the 
melting temperature. This communication contains some of the preliminary results
obtained using the above compounds.
 
Materials and methods 
 
Poly d(A-T) (sodium salt) used for the binding studies was purchased from Boehringer
Mannheim (Lot No. 1443325). The bis and tris (m-benzamido) compounds were
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Figure 2. (a) A projection of the structure of the bis (m-benzamido) compound, (b) A
projection of the structure of the tris (m-benzamido) compound.
The same projections as in figure 1a and 1b have been shown to indicate the curvature.
 
synthesized in this laboratory following a procedure similar to that employed for the 
synthesis of distamycin A (Bialer et al., 1978). Infra-red and nuclear magnetic resonance
spectroscopy were used for characterising these compounds. The solution (1 mM) of 
the bis (m-benzamido) compound was prepared in water and that of tris (m-benzamido) 
compound was prepared in 1:10 ratio of methanol: water mixture. 
Ultra-violet spectroscopy studies were carried out using Beckman DU-8B spectro-
photometer. The reference quartz cell had 20 mM NaCl and the sample quartz cell
contained the poly d (A-T) solution. Different volumes of the bis (m-benzamido) and the 
tris (m-benzamido) compounds were added to 1 ml each of the 20 mM NaCl and the 
poly d(A-T) solutions (in reference and sample cell respectively) corresponding to the
ratios of substrate: poly d(A-T) of 0.1:1, 0.2:1 and 0.5:1 respectively. The peptide 
solution (same volume) was added to both the reference and sample cells, so as to
monitor only the effect due to complexation of poly d(A-T) with the substrates. The
formula: 
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gives the percentage change in absorption at different substrate: poly d(A-T) ratios. The 
absorbance calculated is obtained by incorporation of the volume correction due to the
addition of peptide solution to the fixed volume of the 20 mM NaCl/Poly d(A-T).
Melting temperature studies were also carried out with different ratios of the
substrate to poly d(A-T) as in the ultra-violet spectroscopy studies. The temperatures 
were scanned from 20°-80°C. Freshly prepared solutions of the bis and tris (m- 
benzamido) compounds were used for each experiment, as there was found to be loss of 
absorbance with time. Different volumes of these peptide solutions corresponding to
ratios of 0·1: 1 and 0·2:1 of substrate to poly d(A-T) were added to the sample cells 
containing poly d(A-T). 
Biological activity tests were carried out on a Gram positive bacteria (Staphylococcus
aureus) with both the bis and tris (m-benzamido) compounds by dilution test method.
 
Results
 
Results of the ultra-violet absorption spectroscopy studies on the bis and tris (m- 
benzamido) compounds with poly d(A-T) are shown in figure 3 at the different ratios of 
 
 
Figure 3.    (a) Ultra-violet spectra of poly d(A-T) and the poly d(A-T) complexed with the bis
(m-benzamido) compound for the ratios indicated, (b) Ultra-violet spectra of poly d(A-T) and
the poly d(A-T) complexed with the tris (m-benzamido) compound for the ratios indicated.
 
0·l: 1, 0·2:1 and 0·5; 1 of the substrate: poly d(A-T). It may be noted that there is a
significant hypochromicity at 261 nm in the ultra-violet absorption spectra of the tris
(m-benzamido): poly d(A-T) complex as compared to poly d(A-T) at the different ratios.
A similar but less pronounced effect is seen for the bis (m-benzamido); poly d(A-T)
complex. The hypochromic change observed for the tris complex is about 22% as
compared to about 7 % for the bis complex at the 0·2:1 ratio. The hypochromic change
observed (not shown) for 0·5:1 ratio is 30% for the tris complex and 8 % for the bis 
complex. A small red shift was also observed in the λmax of poly d(A-T) on
complexation. λmax of poly d(A-T) at 261·7 nm shifted to 262·5 nm on addition of the
tris (m-benzamido) compound. The melting profiles of poly d(A-T) and its complexes
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with the bis (m-benzamido) and tris (m-benzamido) compounds are shown in figure 4a 
and 4b respectively for the 0·1:1 and 0·2:1 ratios. The melting/transition temperature 
(tm) of poly d(A-T) alone is at 47°C whereas for the bis (m-benzamido) poly d(A-T) 
complex the tm is at 52°C indicating a 5°C increase in the transition temperature of poly 
d(A-T) on complexation with the bis (m-benzamido) compound. On the other hand, it is
seen from figure 4b that the tm changes from 47°C (poly d(A-T) alone) to 60°C on 
complexation with the tris (m-benzamido) compound at 0·2:1 ratio showing a 12°C
increase in the transition temperature of the tris (m-benzamido): poly d(A-T) complex
as compared to the uncomplexed poly d(A-T).
 
 
Figure 4. (a) Melting profiles of poly d(A-T) and the poly d(A-T) complexed with the bis
(m-benzamido) compound for the ratios indicated. (b) Melting profiles of poly d(A-T) and the
poly d(A-T) complexed with the tris (m-benzamido) compound for the ratios indicated.
 
Preliminary biological activity tests performed on the Gram positive bacteria 
S. aureus by the dilution test method show that there is a zone of inhibition with the tris 
(m-benzamido) compound at concentrations as low as 50 µg as compared to the bis (m- 
benzamido) compound which showed no zone even at 200 µg. Under the same
experimental conditions, distamycin A showed a zone of inhibition only at a
concentration of 125 µg. These tests are indicative of antibacterial activity of the tris (m- 
benzamido) compound. Details of these will be published elsewhere.
 
Discussions 
 
The antibacterial activity studies show some interesting results even though the
preliminary results mentioned above do not establish the comparative strength and
specificity of binding of these (m-benzamido) compounds and netropsin and dis- 
tamycin. The tris (m-benzamido) compound is shown to be more active than
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distamycin A from the biological activity tests carried out on S. aureus. Although, a
number of similar compounds were reported earlier in the literature by several workers
(Atwell and Cain, 1968; Atwell et al., 1968a,b; Cain et al., 1968, 1969; Jones and 
Wooldridge, 1968), there are no reports on the bis and tris (m-benzamido) compounds 
investigated and described in this communication. Earlier studies were mostly carried
out with compounds containing benzene rings linked by peptide units in the para 
positions and therefore do not have the curvature similar to that of netropsin and
distamycin. On the other hand, the meta linkage provides curvature to the molecule as
already described (figure 2a and 2b). The preliminary results obtained by us call for a 
renewed thrust in the synthesis of such molecules using conformational principles to
assure binding to DNA. It is well known that use of distamycin and netropsin as
antimicrobial agents were hampered by their cytotoxicity. Designing of drugs with
similar geometrical, electrostatic and Van der Waals' features as the distamycin class
but with distinct and carefully controlled alterations such as the one described here may 
help find newer and better drugs.
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